FDA Approves Gene Therapy with ISCRM Origins
July 5, 2023 | Categories: Core Faculty, Research |The FDA has approved a first-ever gene therapy for Duchenne muscular dystrophy based in part on technology developed by UW Medicine/ISCRM Researchers Read More
Meet the 2023 Tietze Award Winners
June 1, 2023 | Categories: Award, Core Faculty, Research, Uncategorized |Julie Mathieu, PhD and Niclas Bengtsson, PhD have received prestigious awards from the John H. Tietze Foundation Trust that will help fuel promising research underway in their labs. Read More
Freedman Lab Explores the Role Cilia Play in Signaling, Cell Fate, and Disease Development
April 27, 2022 | Categories: Research |In the Freedman Lab, knocking out primary cilia reveals insights about the role the organelles play in cell fate and disease development. Read More
Regulating Cells With Designed Proteins
March 1, 2022 | Categories: Core Faculty, Research |ISCRM researchers have developed a tool to selectively control the PRC2 complex – an epigenetic regulator that influences cell fate across multiple stages of development. That tool is a computer-designed protein binder engineered in partnership with the Institute for Protein Design (IPD). Read More
Gene Editing May Help Address Arrhythmia Challenges in Heart Regeneration
June 21, 2021 | Categories: Heart Regeneration, Research, Uncategorized |New data presented by ISCRM Director Chuck Murry suggests gene-editing may be the key to clearing a major hurdle for researchers hoping to remuscularize injured hearts with stem cell-derived cardiomyocytes Read More